Edwards Lifesciences Sustainability Profile
Edwards Lifesciences Corporation, a leader in heart valve therapies and critical care monitoring, is headquartered in the United States. Founded in 1958, the company has established itself as a pioneer in the medical technology industry, particularly in the development of innovative solutions for patients with cardiovascular diseases. With a strong presence in North America, Europe, and Asia, Edwards Lifesciences focuses on advanced heart valve replacement and repair technologies, as well as haemodynamic monitoring systems. Their flagship products, including the transcatheter aortic valve replacement (TAVR) systems, are renowned for their unique design and effectiveness, significantly improving patient outcomes. Recognised for its commitment to innovation, Edwards Lifesciences has achieved numerous accolades, solidifying its position as a trusted name in the healthcare sector. The company continues to drive advancements in cardiac care, enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Edwards Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Edwards Lifesciences's score of 82 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Edwards Lifesciences's reported carbon emissions
In 2024, Edwards Lifesciences reported total greenhouse gas emissions of approximately 38,075,000 kg CO2e, comprising 15,682,000 kg CO2e from Scope 1 and 22,393,000 kg CO2e from Scope 2 emissions. The company has set ambitious climate commitments, aiming for carbon neutrality by 2030. This includes a target to reduce absolute Scope 1 and 2 emissions by 42% from a 2021 baseline. Additionally, Edwards aims to cut upstream Scope 3 emissions by 51.6% per USD of value added within the same timeframe. In 2023, the company disclosed total emissions of about 399,030,000 kg CO2e, with Scope 3 emissions accounting for a significant portion at 571,975,000 kg CO2e. The commitment to transition the majority of its global electricity demand to renewable sources is a key strategy in achieving these targets. Edwards Lifesciences's climate initiatives are aligned with the Science Based Targets initiative (SBTi), reinforcing their commitment to limiting global warming to 1.5°C. The company is actively working towards these goals through various methods, including onsite and offsite renewable energy generation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 4,977,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 23,498,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Edwards Lifesciences's Industry?
How Carbon Intensive is Edwards Lifesciences's Location?
Edwards Lifesciences's Scope 3 Categories Breakdown
Edwards Lifesciences's Scope 3 emissions, which increased by 12% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Top Scope 3 Categories
Edwards Lifesciences's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Edwards Lifesciences has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
C. R. Bard, Inc.
CONMED Corporation
Frequently Asked Questions
Common questions about Edwards Lifesciences's sustainability data and climate commitments